Due to health issues, this site is no longer maintained and will be shut down shortly.

SE:ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva, Switzerland. This company has ADRs that trade in the U.S. as the symbol ADXN.

0.23 CHF
As of 03/08/2023

Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Developed markets ex-US
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Switzerland
Country of incorporation:  Switzerland
IPO date:  01/01/1900
Stock exchange:    Six Swiss Exchange
Exchange country:   Switzerland
Market cap:   23,490,002 CHF
Current dividend yield:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy